AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

3.305 +0.085 (+2.64%)
Streaming Delayed Price Updated: 11:43 AM EDT, Mar 28, 2024 Add to My Watchlist

Other Filings

Form REVOKED
Source: SEC/Edgar
December 08, 2013
Form 8-K
Source: SEC/Edgar
August 06, 2012
Form SC 13D
Source: SEC/Edgar
March 14, 2012
Form 8-K
Source: SEC/Edgar
March 04, 2012
Form 8-K
Source: SEC/Edgar
February 16, 2012
Form 8-K
Source: SEC/Edgar
February 01, 2012
Form 8-K
Source: SEC/Edgar
November 22, 2011
Form 8-K
Source: SEC/Edgar
November 09, 2011
Form 10-K/A
Source: SEC/Edgar
September 08, 2010
Form NT 10-Q
Source: SEC/Edgar
August 15, 2010
Form 8-K
Source: SEC/Edgar
July 12, 2010
Form NT 10-Q
Source: SEC/Edgar
May 17, 2010
Form NT 10-K
Source: SEC/Edgar
March 31, 2010
Form NT 10-Q
Source: SEC/Edgar
November 16, 2009
Form NT 10-Q
Source: SEC/Edgar
August 16, 2009
Form 8-K
Source: SEC/Edgar
June 04, 2009
Form NT 10-Q
Source: SEC/Edgar
May 17, 2009
Form NT 10-K
Source: SEC/Edgar
March 31, 2009
Form NT 10-Q
Source: SEC/Edgar
November 16, 2008
Form 8-K
Source: SEC/Edgar
September 21, 2008
Form 8-K
Source: SEC/Edgar
July 24, 2008
Form 8-K
Source: SEC/Edgar
July 17, 2008
Form 8-K
Source: SEC/Edgar
June 02, 2008
Form 10QSB
Source: SEC/Edgar
May 14, 2008
Form 8-K
Source: SEC/Edgar
April 02, 2008
Form 10KSB
Source: SEC/Edgar
March 30, 2008
Form 8-K
Source: SEC/Edgar
January 03, 2008
Form 10QSB
Source: SEC/Edgar
November 13, 2007
Form 10QSB
Source: SEC/Edgar
August 13, 2007
Form 8-K
Source: SEC/Edgar
August 06, 2007
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.